Taken together, we deduced that BRCA1 mutation mediated homologous recombination deficiency (HRD), thus promoting the activation of the TNFα pathway via modulating the JUN and FOS expression, and ultimately induces the iCAF phenotype. This evidence concerns the gene JUN and hypoparathyroidism-retardation-dysmorphism syndrome.